Hemab Therapeutics Holdings (COAG) PT Raised to $47 at Jefferies
Tweet
Share
E-mailGet Alerts COAG Hot Sheet
Price: $40.97 --0%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 9 | New: 32
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 9 | New: 32
Join SI Premium – FREE
Jefferies analyst Maury Raycroft raised the price target on Hemab Therapeutics Holdings (NASDAQ: COAG) to $47.00 (from $39.00) while maintaining a Buy rating.
You May Also Be Interested In
- Enova International (ENVA) PT Lowered to $205 at Stephens
- Huntington Bancshares (HBAN) PT Lowered to $21 at Wells Fargo
- ACG Metals Ltd (ACG:LN) PT Lowered to GBP22.95 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
